The invention discloses a controlled release dosage form comprising a therapeutically effective amount of a pharmaceutically active agent, illustrated by Acyclovir, that would release in about 12 hours not more than about 90% of the said active agent in a simulated gastric juice in a first order rate of release in a...

The invention comprises an oral Omega-3-fatty acid-rich oil emulsion composition comprising DHA 50-100 mg/ml, made from all natural and biocompatible ingredients for use in management of treatment of a disorder to overcome the same. The composition may be a thixotropic emulsion in nanometric size range having better...

The invention comprises an oral Omega-3-fatty acid-rich oil emulsion composition comprising DHA 50-100 mg/ml, made from all natural and biocompatible ingredients for use in management of treatment of a disorder to overcome the same. The composition may be a thixotropic emulsion in nanometric size range having better...